Physician profile
Kurt Von Rueden
NPI 1114975893
$20,226.83
in general payments reported to CMS, 2019-2025
4 companies · $1,854 in 2025
The $1,854 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,904 · 2020: $3,746 · 2022: $4,571 · 2023: $1,671 · 2024: $2,480 · 2025: $1,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5,991 · Food and Beverage: $14.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,990.86 |
| Food and Beverage | $14.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $10,248.81 | 2019-2022 | |
| Zimvie INC. | $5,629.03 | 2022-2023 | |
| Highridge Medical LLC | $4,334.27 | 2024-2025 | Zyston Strut |
| Abbott Laboratories | $14.72 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Von Rueden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.